151 related articles for article (PubMed ID: 38383255)
1. CT-derived radiomics predict the growth rate of renal tumours in von Hippel-Lindau syndrome.
Singh S; Dehghani Firouzabadi F; Chaurasia A; Homayounieh F; Ball MW; Huda F; Turkbey EB; Linehan WM; Malayeri AA
Clin Radiol; 2024 May; 79(5):e675-e681. PubMed ID: 38383255
[TBL] [Abstract][Full Text] [Related]
2. An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndrome.
Anari PY; Lay N; Gopal N; Chaurasia A; Samimi S; Harmon S; Firouzabadi FD; Merino MJ; Wakim P; Turkbey E; Jones EC; Ball MW; Turkbey B; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2022 Oct; 47(10):3554-3562. PubMed ID: 35869307
[TBL] [Abstract][Full Text] [Related]
3. Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau Disease.
Farhadi F; Nikpanah M; Paschall AK; Shafiei A; Tadayoni A; Ball MW; Linehan WM; Jones EC; Malayeri AA
Radiology; 2020 Jun; 295(3):583-590. PubMed ID: 32255415
[TBL] [Abstract][Full Text] [Related]
4. Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.
Schuhmacher P; Kim E; Hahn F; Sekula P; Jilg CA; Leiber C; Neumann HP; Schultze-Seemann W; Walz G; Zschiedrich S
Orphanet J Rare Dis; 2019 Oct; 14(1):235. PubMed ID: 31661010
[TBL] [Abstract][Full Text] [Related]
5. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
Choyke PL; Glenn GM; Walther MM; Zbar B; Weiss GH; Alexander RB; Hayes WS; Long JP; Thakore KN; Linehan WM
AJR Am J Roentgenol; 1992 Dec; 159(6):1229-34. PubMed ID: 1442389
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic metastases from renal cell carcinoma in von Hippel-Lindau disease.
Chambers TP; Fishman EK; Hruban RH
Clin Imaging; 1997; 21(1):40-2. PubMed ID: 9117930
[TBL] [Abstract][Full Text] [Related]
7. Germline VHL gene variant in patients with von Hippel-Lindau disease does not predict renal tumor growth.
Farhadi F; Nikpanah M; Li X; Symons R; Pourmorteza A; Merino MJ; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Oct; 43(10):2743-2749. PubMed ID: 29525880
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H
Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective.
Li ZC; Zhai G; Zhang J; Wang Z; Liu G; Wu GY; Liang D; Zheng H
Eur Radiol; 2019 Aug; 29(8):3996-4007. PubMed ID: 30523454
[TBL] [Abstract][Full Text] [Related]
10. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
[TBL] [Abstract][Full Text] [Related]
11. CT diagnosis of unsuspected von Hippel-Lindau disease.
Kuhlman JK; Fishman EK; Marshall FF; Siegelman SS
Urology; 1987 Nov; 30(5):505-8. PubMed ID: 3672691
[TBL] [Abstract][Full Text] [Related]
12. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients.
Peng X; Chen J; Wang J; Peng S; Liu S; Ma K; Zhou J; Hong B; Zhou B; Zhang J; Cai L; Gong K
J Med Genet; 2019 Jun; 56(6):380-387. PubMed ID: 30745424
[TBL] [Abstract][Full Text] [Related]
13. Can whole-tumor radiomics-based CT analysis better differentiate fat-poor angiomyolipoma from clear cell renal cell caricinoma: compared with conventional CT analysis?
Ma Y; Cao F; Xu X; Ma W
Abdom Radiol (NY); 2020 Aug; 45(8):2500-2507. PubMed ID: 31980867
[TBL] [Abstract][Full Text] [Related]
14. [A case of renal cell carcinoma and bladder carcinoma associated with von Hippel-Lindau disease].
Kinbara H; Suzuki S; Nakano S; Yamakawa K; Hioki T; Okabe S; Sugimura Y; Tajima K; Tochigi H; Kawamura J
Hinyokika Kiyo; 1990 Jul; 36(7):823-6. PubMed ID: 2239580
[TBL] [Abstract][Full Text] [Related]
15. The kidney imaging surveillance scoring system (KISSS): using qualitative MRI features to predict growth rate of renal tumors in patients with von-Hippel Lindau (VHL) syndrome.
Gopal N; Anari PY; Chaurasia A; Antony M; Wakim P; Linehan WM; Ball M; Turkbey E; Malayeri A
Abdom Radiol (NY); 2024 Feb; 49(2):542-550. PubMed ID: 38010527
[TBL] [Abstract][Full Text] [Related]
16. A Von Hippel-Lindau Disease-Associated Microcystic Adenoma of the Ethmoid Sinus Mimicking Metastatic Clear Cell Renal Cell Carcinoma.
Tsukamoto S; Koyasu S; Sugimoto A; Matsunaga M; Nakamoto Y
Clin Nucl Med; 2023 Feb; 48(2):194-196. PubMed ID: 36179325
[TBL] [Abstract][Full Text] [Related]
17. Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade.
Shu J; Tang Y; Cui J; Yang R; Meng X; Cai Z; Zhang J; Xu W; Wen D; Yin H
Eur J Radiol; 2018 Dec; 109():8-12. PubMed ID: 30527316
[TBL] [Abstract][Full Text] [Related]
18. CT-based radiomics for differentiating renal tumours: a systematic review.
Bhandari A; Ibrahim M; Sharma C; Liong R; Gustafson S; Prior M
Abdom Radiol (NY); 2021 May; 46(5):2052-2063. PubMed ID: 33136182
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.
Neumann HP; Bender BU; Berger DP; Laubenberger J; Schultze-Seemann W; Wetterauer U; Ferstl FJ; Herbst EW; Schwarzkopf G; Hes FJ; Lips CJ; Lamiell JM; Masek O; Riegler P; Mueller B; Glavac D; Brauch H
J Urol; 1998 Oct; 160(4):1248-54. PubMed ID: 9751329
[TBL] [Abstract][Full Text] [Related]
20. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Ardelt PU; Schwardt M; Schultze-Seemann W
Urol Int; 2012; 88(1):71-8. PubMed ID: 22156657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
